Lessons learned from past passive immunization trials to prevent HIV MTCT
|
|
- Georgina Watson
- 5 years ago
- Views:
Transcription
1 Lessons learned from past passive immunization trials to prevent HIV MTCT Laura Guay MD EGPAF Vice President for Research Research Professor, George Washington University SPH
2 PACTG 185 Outline HIVIGLOB Phase I/II HIVIGLOB Phase III Community/Participant trial preparation
3 PACTG 185 Design Multicenter, randomized controlled HIV Hyperimmune Immunoglobulin (HIVIG) trial in US and Puerto Rico HIVIG (North American Biologicals, Boca Raton, FL) plus zidovudine (ZDV) compared with intravenous immunoglobulin (IVIG) plus ZDV in HIV-positive pregnant women with CD4 counts < 500 cells/µl receiving standard ZDV regimen at the time HIVIG or IVIG 200 mg/kg IV to women every 4 weeks from weeks gestation to delivery Infant IV infusion of HIVIG or IVIG (arm same as mother) 200 mg/kg within 12 hours of birth Target- 400 pairs per arm; stopped for futility after 501 enrolled
4 PACTG 185 PK and Safety Results Pharmacokinetics: Maternal mean half-life after 1 and 3 infusions was 15 and 32 days respectively Newborn half-life was 30 days HIVIG rapidly cleared p24 antigenemia with no change in RNA levels The HIVIG was safe and well tolerated by the pregnant women and their neonates. Side effects seen were common to immunoglobulin infusions 6 women and no infants discontinued infusion due to side effects No difference between arms
5 PACTG 185 Efficacy Results Kaplan-Meier estimated transmission rate by treatment arm was 4.1% (95% CI, 1.5% 6.7%) in HIVIG and 6.0% (95% CI, 2.8% 9.1%) in IVIG recipients (P=.36) There was a difference between treatment arms in the distribution of infants who had a positive HIV culture at birth (none in HIVIG vs. 5 in IVIG recipients; P 5.05). Trend toward lower transmission among women receiving HIVIG who started ZDV before pregnancy (1.9% in HIVIG vs. 9.2% in IVIG recipients; P=.09 ) or who had baseline CD4 cell count <200 µl (5.6% in HIVIG vs. 14.9% in IVIG recipients; P =.12).
6 HIVIGLOB Phase I/II Design Safety, tolerance, PK, and virologic and immunologic changes associated with Ugandan HIV hyperimmune globulin (HIVIGLOB) in HIV infected pregnant Ugandan women and their infants HIVIGLOB prepared from Ugandan discarded units of HIV infected blood (CD4 cells>500, p24 ag neg) at the Swedish Institute for Infectious Disease Control fold reduction in infectivity against primary subtype isolates (B,C,E, A, but not D) contained 98% monomeric IgG. IgG subclass enzyme immuno-assays on the 16% HIVIGLOB solution: titer of IgG1 antibody to rgp160= 1: ; rp24 =1: ; LP2-V3/MN-peptide =1: A prospective, phase I/II, three-arm dose escalation trial of 50, 200, and 400 mg/kg HIVIGLOB in 31 women at 37 weeks gestation and infants within 16 hrs of birth ( ).
7 HIVIGLOB Phase I/II Results All three dosing levels were well tolerated by women and infants Common side effects associated with immunoglobulin infusions 2 neonatal deaths prior to HIVIGLOB infant infusion High pre-infusion p24 antibody titers in pregnant women 1: (range, 1:25 to 1: ) Maternal p24 antibody t1/2 in three dosing groups (50, 200, 400 mg/kg) were 27, 15, and 29 days respectively Cord blood median p24 antibody titer= 1: (range, 1:1437 to 1: ) Infant p24 antibody t1/2 in three dosing groups were 30 days, 32 days, and 29 days
8 HIVIGLOB Phase I/II Results Significant increases in p24 antibody postinfusion only in 400 mg/kg dose No significant changes in HIV RNA or CD4 cell counts post-infusion in any arm No women had p24 antigenemia prior to infusion Lowest transmission in 400 mg/kg group but numbers too small to make transmission conclusions
9 HIVIGLOB Phase III design Phase III, randomized, clinical trial of single-dose nevirapine (sdnvp) plus HIVIGLOB compared with sdnvp for PMTCT in HIV positive pregnant women and their infants in Kampala. 2 out of 3 arms of a multi-country trial including extended NVP to 6 weeks arm, not included in analysis Single intravenous 240-mL dose (~200 mg/kg) of HIVIGLOB to women at weeks gestation Single intravenous 24-mL (~400 mg/kg) dose to newborns within 18 hours of birth Study recruitment
10 HIVIGLOB Phase III Results 204 pairs in HIVIGLOB arm in sdnvp arm Only 173 (85%) of women received infusion mostly due to delivery prior to infusion 4 infants did not get HIVIGLOB (2 neonatal deaths, 2 refusals) HIVIGLOB was safe and well tolerated No difference in AE between arms Common side effects for IV immunoglobulins 14 infants had possibly related SAEs: 8 during the infusion (1 discontinuation, 2 temporarily held, and 5 no change in infusion); 6 after completion of the infusion. 2 infant deaths at home within 1 and 3 days of birth where some contribution of HIVIGLOB could not be ruled out. Women asked for more - felt much better after getting infusion
11 HIVIGLOB Phase III Efficacy Results Interpretation of the HIVIGLOB efficacy was complicated by the unanticipated low rate of HIV infection at birth in the sdnvp control arm (4.1%), significantly lower than the HIVIGLOB/sdNVP arm (9.1%) and the rates seen with the same sdnvp regimen in the third arm of this trial (9.6%) The difference persisted throughout the study period; however, it was no longer statistically significant by the 6- week time point. The difference in the proportion of HIV infected children at 6 months, the primary endpoint, was not statistically significant between the HIVIGLOB/sdNVP arm and the sdnvp arm (18.7% vs. 15.0%, RR = 1.240, 95% CI: to 1.846, P = 0.290).
12 Community sensitization Multiple stakeholder meetings, but primarily scientific: MOH, IRBs, other HIV researchers, health facility staff Better community sensitization with later HIV Vaccine trial (HPTN 027 infant ALVAC) than with the early passive immunization studies. Added UNEPI to technical meetings due to concern re effect of HIV vaccine on standard infant immunizations CAB engagement including adult HIV vaccine participants Media training on trial and general vaccine information Study summary, key messages, and Q&A information provided to leaders (HIV and others) in country
13 Participant Study Preparation Multiple step process of providing information and obtaining informed consent Consent form pictorial flip chart (English and Luganda) Provided tool for counselors to use Attempt to convey key messages to women Provide explanation about what antibodies are, why product is from HIV infected donors but does not contain HIV Assessment of understanding conducted by person other than one obtaining consent
14 GROUP 2, 200 women Mother Baby NVP + Syringe used to give baby syrup by mouth HIVIGLOB + NVP HIVIGLOB + NVP
15 HIV infected cell HIV antibody Cell with HIV + HIV antibody HIV antibodies are taken out of the blood and made into HIVIGLOB
16 Practical considerations Acceptability of IV infusions- need to establish smooth system for IV infusion that will minimize obstacles to participation Separate room in postnatal ward for HIVIGLOB infusions for women; infused babies in the special care unit (more skilled nurses, proximity to emergency equipment/care, privacy) Need to address confidentiality for non-disclosed partners/family members Delay in clinic/maternity Background neonatal sepsis and death rates have to be considered in study populations due to temporal association with infusion.
17 THANK YOU!
CCC ARV Dosing Recommendations for HIV-exposed infants Updated
USERS NOTE: Please note this document does not provide guidance on overall decisionmaking regarding what medication(s) to use for HIV-exposed infants. This document is meant to facilitate ARV dosing for
More informationWales Neonatal Network Guideline CARE OF THE BABY WHO HAS BEEN BORN TO AN HIV POSITIVE MOTHER
CARE OF THE BABY WHO HAS BEEN BORN TO AN HIV POSITIVE MOTHER A plan of care is written for all babies to be born to a woman with HIV infection. These are placed in the maternal notes within the Baby Pack
More informationCost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a lowprevalence
Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a lowprevalence setting Rely K, Bertozzi S M, Avila-Figueroa C, Guijarro M T Record Status This is a critical abstract
More information1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London
A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell
More informationManagement of the HIV-Exposed Infant
Management of the HIV-Exposed Infant Katherine Knapp, MD Medical Director, Perinatal Program Department of Infectious Diseases St. Jude Children s Research Hospital Disclosures No conflicts of interest
More informationPhase II clinical trial TEmAA. Didier Koumavi EKOUEVI, MD PhD (Principal Investigator)
The combination of Tenofovir-Emtricitabine (Truvada ): a new antiretroviral (ARV) regimen for the prevention of mother-to-child transmission of HIV-1 (PMTCT) in resource-limited settings Phase II clinical
More informationANTIRETROVIRAL (ART) DRUG INFORMATION FOR HEALTH CARE PROFESSIONAL
ZIDOVUDINE (AZT, Retrovir ) Benefits of zidovudine: Zidovudine (ZDV) is an antiretroviral drug that slows the growth of the HIV virus. It has shown in a large randomized, multicentre study to decrease
More informationWhat s New in Prevention of Mother to Child HIV Transmission
Koff WC. NEJM 2010;363:e7 What s New in Prevention of Mother to Child HIV Transmission i And Why We Still Need an HIV Vaccine for Infants Lynne M Mofenson M D Lynne M. Mofenson, M.D. Pediatric, Adolescent
More informationCUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More informationThe Promise of HIV Prevention in Pregnancy. Richard H. Beigi, MD., MSc. University of Pittsburgh Pittsburgh, PA USA
The Promise of HIV Prevention in Pregnancy Richard H. Beigi, MD., MSc. University of Pittsburgh Pittsburgh, PA USA Outline Pregnancy/Lactation Brief background Where we were Where we are now Where we are
More informationInfertility Treatment and HIV
Infertility Treatment and HIV Infertility Treatment by IVF Or Intra-cytoplasmic Sperm Injections (ICSC) In Chronic HIV-1 Sero- discordant Couples (Poster 670) Retrospective study of outcome of IVF or ICSC
More informationJournal Club 3/4/2011
Journal Club 3/4/2011 Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants JAMA. 2011 Feb 9;305(6):576-84. Jones et al Dept of Pediatrics, Imperial College,
More informationPREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW
PREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW *Nunung Nurhayati STIKep PPNI Jawa Barat, Bandung, West Java Indonesia Email: nunky_adzra@yahoo.com ABSTRACT Baby risk be infected HIV/AIDS
More informationPeter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1
OUTCOMES OF HIV EXPOSED INFANTS BEFORE AND AFTER IMPLEMENTING OPTION B+ PMTCT GUIDELINE IN KAMPALA,UGANDA: A RETROSPECTIVE COHORT STUDY. Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang
More informationReports of efficacy and safety studies of primary immunodeficiency
2. SYNOPSIS TITLE OF STUDY: Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of IGIV3I GRIFOLS [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency
More informationUsing Implementation Science to Address Prevention of Mother to Child Transmission of HIV
Using Implementation Science to Address Prevention of Mother to Child Transmission of HIV Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Founda@on 1 The role of Implementation
More informationFigure S1: Overview of PMTCT Options A and B. Prevention of Mother to Child HIV Transmission (PMTCT)
Figure S1: Overview of PMTCT Options A and B Prevention of Mother to Child HIV Transmission (PMTCT) Option A: combined Antiretroviral therapy (ART) for all women meeting WHO 2010 criteria for initiation
More informationThe Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine
The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine A retrospective, descriptive study conducted at Kalafong hospital,
More informationTOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV
TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV Gladwel Muthoni KPA Conference 24 th April, 2018 OUTLINE Burden of HIV in PMTCT Mechanism and timing of Mother to Child Transmission (MTCT) Four
More informationWhat Women Need to Know: The HIV Treatment Guidelines for Pregnant Women
: The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women What Women Need to Know: Prepared by Elaine Gross, RN, MS, CNS-C National Pediatric & Family HIV Resource
More informationTHE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
More informationA Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia
ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT
More informationSafe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland
Safe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland Background and Rationale In 2015, the World Health Organization (WHO) endorsed universal treatment for
More informationShould we treat hepatitis B positive pregnant women to prevent mother to child transmission?
Should we treat hepatitis B positive pregnant women to prevent mother to child transmission? Daniel Shouval Liver Unit Hadassah-Hebrew University Hospital Jerusalem, Israel VHPB Vienna June 1-2, 2017 Background
More informationDr Graham P Taylor Reader in Communicable Diseases
HIV in Pregnancy Joint RCOG/BHIVA Multidisciplinary Conference Dr Graham Taylor Imperial College London Friday 20 January 2012, Royal College of Obstetricians and Gynaecologist, London Prevention of post-partum
More informationFunding and Impact of Biomedical and Health Research
Funding and Impact of Biomedical and Health Research 1 Laura Guay MD Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation Research Professor, George Washington University School of Public
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationMichigan Guidelines: HIV, Syphilis, HBV in Pregnancy
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy Presenter: Theodore B. Jones, MD Maternal Fetal Medicine Wayne State University School of Medicine Beaumont Dearborn Hospital HIV, Syphilis, HBV in
More informationImpact of Option B on mother-to-child HIV transmission in Rwanda: an interrupted time series analysis
Impact of Option B on mother-to-child HIV transmission in Rwanda: an interrupted time series analysis Monique Abimpaye, Hari S. Iyer, Michael Law, Catherine Kirk, Eric Remera, Placidie Mugwaneza, Neil
More informationRecommended Clinical Guidelines on the Prevention of Perinatal HIV Transmission
Recommended Clinical Guidelines on the Prevention of Perinatal HIV Transmission Scientific Committee of the Advisory Council on AIDS, Hong Kong April 2001 Preamble Recommended clinical guidelines on the
More informationAll HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis. Against the motion
All HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis Against the motion Hermione Lyall Imperial Healthcare NHS Trust, London, UK Acknowledgements: Pat Tookey, Ali Judd, Claire
More informationImpact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines
Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Thu-Ha Dinh, MD., MS., US CDC/GAP Ameena Goga, MD., MS., MRC/HSRU,
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationPerinatal HIV Exposure: Antiretroviral Management. Danielle McDonald, PharmD PGY-2 Pediatric Pharmacotherapy Resident
Perinatal HIV Exposure: Antiretroviral Management Danielle McDonald, PharmD PGY-2 Pediatric Pharmacotherapy Resident A presentation for HealthTrust Members June 1, 2018 Learning Objectives for Pharmacists
More informationHIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI
HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV
More informationDECLINE IN POSITIVITY RATES AMONG HIV-EXPOSED INFANTS WITH CHANGES IN PMTCT ARV REGIMENS IN NIGERIA: EVIDENCE FROM 7 YEARS OF FIELD IMPLEMENTATION
Abst#_O_01 DECLINE IN POSITIVITY RATES AMONG HIV-EXPOSED INFANTS WITH CHANGES IN PMTCT ARV REGIMENS IN NIGERIA: EVIDENCE FROM 7 YEARS OF FIELD IMPLEMENTATION Hadiza Khamofu, 1 Edward Oladele, 1 Uche Ralph-Opara,
More informationApplying Improvement to Keep HIV+ Mothers and Exposed Infants in Care. Anisa Ismail Improvement Advisor University Research Co.
Applying Improvement to Keep HIV+ Mothers and Exposed Infants in Care Anisa Ismail Improvement Advisor University Research Co., LLC 1 What if you found out you were pregnant? What if you knew you were
More informationPreliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi
Preliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi Spencer Nundwe 1, Oren Jalon 2, Reinaldo Ortuno 2, Carol Metcalf 3, Sarah Daho 1, Helen Bygrave 3, Michael Murowa 4, Kingsley
More informationSCENARIO. Maternal Medicine- Intrapartum HIV LEARNING OBJECTIVES
SCENARIO Maternal Medicine- Intrapartum HIV LEARNING OBJECTIVES To be aware of the management of unbooked women with an unknown HIV status Be able to counsel women on potential new diagnosis of HIV To
More informationROLE OF ANTIRETROVIRAL THERAPY IN HIV POSITIVE PREGNANT WOMEN
Page1 Research Article Biological Sciences ROLE OF ANTIRETROVIRAL THERAPY IN HIV POSITIVE PREGNANT WOMEN P.S.Rashmi 1, Hegde Kiran 2, Patil Rajashri 3, Vijayanath.V 4* 1 Department of Obstetrics & Gyeanecology,
More informationHistoric Perspective on HIV and TB Research in Pregnant Women
Historic Perspective on HIV and TB Research in Pregnant Women Lynne M. Mofenson, M.D. Senior HIV Technical Advisor Elizabeth Glaser Pediatric AIDS Foundation High Burden of TB/HIV in Women - 2016 TB HIV
More informationCase Report Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin
Case Reports in Infectious Diseases, Article ID 234545, 4 pages http://dx.doi.org/10.1155/2014/234545 Case Report Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin Yasemin
More informationThe Global Partnership for HIV-Free Survival (PHFS): Quality Improvement and Breastfeeding / ART compliance
The Global Partnership for HIV-Free Survival (PHFS): Quality Improvement and Breastfeeding / ART compliance TOPS Breastfeeding Seminar Washington, DC May 10, 2017 Amy F. Stern, URC Improvement Director
More informationThe New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator
The New National Guidelines (2010) for PMTCT and Infant Feeding in the Context of HIV Dr. Godfrey Esiru; National PMTCT Coordinator Presentation outline Evolution of the PMTCT guidelines in Uganda Rational
More informationSouth African goals and national policy
Connecting the dots for EMTCT A Decade of PMTCT South Africa has been one of the counties in sub-saharan Africa to be hard hit by the HIV virus. Despite this, the country did not implement its PMTCT programme
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationPMTCT Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town
PMTCT 2010 Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town Prevention of Mother-To-Child Transmission of HIV or Prevention
More informationConcerning Testing of Pregnant Women and Newborns for HIV: Sindy M. Paul, MD, MPH, FACPM October 27, 2009
PL 2007 c 218 An Act Concerning Testing of Pregnant Women and Newborns for HIV: The Regulations Sindy M. Paul, MD, MPH, FACPM October 27, 2009 The Process Legislation signed into law Legislation requires
More informationLRI Children s Hospital. Management of chicken pox exposure in paediatrics
LRI Children s Hospital Management of chicken pox exposure in paediatrics Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: October 018 Version: V 3 Revision
More informationNOTICE TO PHYSICIANS. Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health
NOTICE TO PHYSICIANS DATE: March 10, 2003 TO: FROM: SUBJECT: HIV/AIDS Health Care Providers Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health
More informationHIV infection in pregnancy
HIV infection in pregnancy Peter Brocklehurst National Perinatal Epidemiology Unit, University of Oxford What is the size of the problem? in the population as a whole? in women? in pregnant women? in children?
More informationDr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM
Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM SA Background Population: 48m Annual number of deliveries:1,2m 97% of women attend the first ANC 71% of women attend 5 th ANC visit 97% of
More informationUse of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH
Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH University of Pittsburgh Medical Center Disclosures Presenter has no financial interests to
More informationProgress & challenges in PMTCT: The unfinished agenda
Progress & challenges in PMTCT: The unfinished agenda Dr Chewe Luo MMED (Paed); MTropPaed; PhD; FRCP Senior Adviser and Team Leader Country Programme Scale Up HIV Section, Programme Division UNICEF NY,
More informationTunisian recommendations on ART : process and results
Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN
More informationStigma and discrimination as barriers to achievement of global PMTCT and maternal health goals
Stigma and discrimination as barriers to achievement of global PMTCT and maternal health goals Janet M. Turan University of Alabama at Birmingham Laura Nyblade USAID-funded Health Policy Project Woodrow
More informationInfant feeding in the ARV era. Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital
Infant feeding in the ARV era Gerhard Theron Gerhard Theron Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital Global HIV infections: 2007 12 countries account for
More informationPrevention of Perinatal HIV Transmission
Prevention of Perinatal HIV Transmission Emily Adhikari, MD Division of Maternal-Fetal Medicine Obstetrics and Gynecology University of Texas Southwestern Medical Center February 20, 2018 None Understand
More informationStrengthening the Integration of PMTCT within MNCH Services
Strengthening the Integration of PMTCT within MNCH Services ACCESS APPROACH While not planned as a major focus of the ACCESS Program, the prevention of mother-to-child transmission of HIV/AIDS (PMTCT)
More informationChallenges of HIV drug resistance in resource-limited settings
Challenges of HIV drug resistance in resource-limited settings Marie-Louise Newell Professor of Global Health Faculty of Medicine and Faculty of Social and Human Sciences, University of Southampton, UK
More informationObstetrics and HIV An Update. Jennifer Van Horn MD University of Utah
Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management
More information2016 Perinatal Treatment Guidelines Update
Mountain West AIDS Education and Training Center 2016 Perinatal Treatment Guidelines Update Shireesha Dhanireddy, MD Associate Professor of Medicine, University of Washington 2 November 2016 This presentation
More informationUpdate on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines
WHO 2013 Consolidated ARV Guidelines Update on global guidelines H I V / A I D S DEPARTMENT and emerging issues on perinatal HIV prevention Children & HIV, St. Petersburg, Russia Sept 25-26, 2014 Dr. Nathan
More informationMalaysian Consensus Guidelines on Antiretroviral Therapy Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh
Malaysian Consensus Guidelines on Antiretroviral Therapy 2017 Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh Acknowledgement Table of contents Evolution of when to initiate therapy ART improves survival
More informationAMERICAN INTERNATIONAL HEALTH ALLIANCE
AMERICAN INTERNATIONAL HEALTH ALLIANCE CAPACITY BUILDING TO PREVENT MOTHER-TO-CHILD TRANSMISSION OF HIV IN UKRAINE 2005-2008 UPDATE TO THE FINAL REPORT December, 2008 USAID Annual Program Statement Grant
More informationThe Contribution of Family Planning towards the Prevention of HIV Mother-to-Child Transmission (PMTCT) in Uganda
The Contribution of Family Planning towards the Prevention of HIV Mother-to-Child Transmission (PMTCT) in Uganda Wolfgang Hladik CDC Uganda The findings and conclusions in this presentation are those of
More informationPREGNANCY OUTCOMES AMONG HIV-INFECTED WOMEN IN UGANDA AND ZIMBABWE
PREGNANCY OUTCOMES AMONG HIV-INFECTED WOMEN IN UGANDA AND ZIMBABWE Kathryn Lancaster, MPH 3rd International Workshop on HIV & Women January 15, 2013 HIV among women of reproductive age Women of reproductive
More informationIntegrating PMCT in RH / MCH services in Myanmar. 6 November 2006 At Kuala Lumpur
Integrating PMCT in RH / MCH services in Myanmar 6 November 2006 At Kuala Lumpur Country profile 14 states and divisions, 63 districts, and 325 townships Population in 2005 was 55.40 million (estimated)
More informationOutline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?
Prevention of mother-to-child transmission of HIV Outline AimofPMTCT How HIV is transmitted to children Epidemiology of HIV in children How to reduce HIV transmission to children Guidelines Lars T. Fadnes
More informationKingdom of Cambodia Nation Religion King
Kingdom of Cambodia Nation Religion King MINISRY OF HEALTH Joint NCHADS-NCMCH (*) Statement On the Implementation of the Prevention of Mother-to-Child Transmission of HIV/AIDS 1. Introduction The prevalence
More informationCalifornia Perinatal Quality Care Collaborative 2013 Standards of Care for the Prevention of Perinatal HIV Transmission
2013 Revised Edition Authors: David K Hong, MD, Nivedita Srinivas, MD Original Authors: Mary Campbell Bliss, RN, MS, CNS, William Gilbert, MD, Jan Lanouette, MD, Courtney Nisbet, RN, MS, David Wirtschafter,
More informationWomen are the fastest-growing group of persons with
Clinical Guidelines Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force Roger Chou, MD; Ariel K. Smits, MD, MPH; Laurie Hoyt Huffman, MS; Rongwei Fu, PhD; and
More informationThe Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT
The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT Peter McDermott Managing Director, CIFF 19 th Board meeting, Geneva 6 th May 2009 Investment Criteria Measurable...change
More informationPrevention of Mother to Child Transmission of HIV: Our Experience in South India
pg 62-66 Original Article Prevention of Mother to Child Transmission of HIV: Our Experience in South India Karthekeyani Vijaya 1, Alexander Glory 2, Solomon Eileen 3, Rao Sarita 4, Rao P.S.S.Sunder 5 1
More informationInformation for professionals for Cytotect CP Biotest: Biotest (Switzerland) AG Complete information for professionals DDD Print
Information for professionals for Cytotect CP Biotest: Biotest (Switzerland) AG Complete information for professionals DDD Print Composition 1 ml solution contains: Active ingredients:. plasma proteins
More informationINTERPROFESSIONAL PROTOCOL - MUHC
INTERPROFESSIONAL PROTOCOL - MUHC Medication included No Medication included THIS IS NOT A MEDICAL ORDER Title: PREVENTION OF MATERNAL TO INFANT HIV INFECTION Intrapartum, Peripartum, and Postpartum Antiretroviral
More informationin pregnancy Document Review History Version Review Date Reviewed By Approved By
GYNAECOLOGY/ ANTENATAL CARE WIRRAL WOMEN & CHILDREN S HOSPITAL Guideline No: Hepatitis B management in pregnancy VERSION 1 AMENDMENTS MADE: N/A DATE OF ISSUE: May 2012 DATE OF REVIEW: May 2015 REVIEW INTERVAL:
More informationAppendix 1: summary of the modified GRADE system (grades 1A 2D)
Appendix 1: summary of the modified GRADE system (grades 1A 2D) 1A 1B 1C 1D 2A 2B 2C 2D Strong recommendation High-quality evidence Benefits clearly outweigh risk and burdens, or vice versa Consistent
More informationAcceptability of HPTN 077. The George Washington University HPTN Clinical Research Site 16 June 2016
Acceptability of HPTN 077 The George Washington University HPTN Clinical Research Site 16 June 2016 Outline The epidemic in DC Prior HPTN studies, the context for injections Our experience with HPTN 077
More informationEarly Antiretroviral Therapy in Newborns: Opportunities and Challenges. Ellen Gould Chadwick MD Northwestern University Feinberg School of Medicine
Early Antiretroviral Therapy in Newborns: Opportunities and Challenges Ellen Gould Chadwick MD Northwestern University Feinberg School of Medicine Conflict of Interest Disclosures for Ellen Chadwick MD
More informationRESEARCH. All Photos: Eric Bond/EGPAF,2017
RESEARCH All Photos: Eric Bond/EGPAF,2017 The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a recognized global leader in the fight to end pediatric HIV/AIDS through research, advocacy, and delivery
More informationCROI 2016 Update NEAETC, March 21, Sigal Yawetz, MD Brigham and Women s Hospital Harvard Medical School
CROI 2016 Update NEAETC, March 21, 2016 Sigal Yawetz, MD Brigham and Women s Hospital Harvard Medical School CROI 2016 Update NEAETC, March 21, 2016 UNITED STATES EPIDEMIOLOGY Estimating the lifetime risk
More informationDEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr.
2013 Consolidated ARV Guidelines H I V / A I D S Treatment Recommendations for DEPARTMENT Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer Objectives of Presentation obackground ooverview
More informationGlobal Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org
More informationPreventing Mother to Child HIV Transmission: Are We There Yet?!'
Preventing Mother to Child HIV Transmission: Are We There Yet?!' 2017 Michigan Clincal Nursing Conference for HIV and STD Care May 18, 2017 Frankenmuth MI 1 Theodore B. Jones, MD Maternal Fetal Medicine
More informationPrevention of Mother-to-Child Transmission of HIV Infection
HIV Curriculum for the Health Professional Prevention of Mother-to-Child Transmission of HIV Infection Michael A. Tolle, MD, MPH Daniel Dewey, MD Objectives 1. Describe the scope of mother-to-child transmission
More informationDiscontinuation of cart postpartum in a high prevalence district of South Africa in 2014
Claessens et al. Implementation Science 2014, 9:139 Implementation Science STUDY PROTOCOL Open Access Discontinuation of cart postpartum in a high prevalence district of South Africa in 2014 Lore Claessens
More informationInfant feeding and HIV Policy, Evidence and Hospital Challenges
Infant feeding and HIV Policy, Evidence and Hospital Challenges Max Kroon MMH/SCAH MY BRIEF Overview of infant feeding within the PMTCT program including national policy, feeding choices & research evidence
More informationIMPORTANT HEALTH INFORMATION
IMPORTANT HEALTH INFORMATION SU-6523MI Page 1 of 8 Table of Contents Page What is an HIV test?..........................................1 Will the HIV test tell me if I have AIDS?............................1
More informationHIV/AIDS Prenatal Care for HIV+ Mothers. 1. Algorithm for Prenatal Screening & Care (Antepartum)
7/10/18 njm 1. Algorithm for Prenatal Screening & Care (Antepartum) 2. Algorithm for Prenatal HIV Screening and Care (Mother refuses screening) 3. Algorithm for Intrapartum Care 4. Prenatal Care for HIV+
More informationTransmission of Group B Streptococcus in Malawi: A Prospective Cohort Study
Transmission of Group B Streptococcus in Malawi: A Prospective Cohort Study DR. YO NISHIHARA, MBBS, MRCPCH MALAWI-LIVERPOOL-WELLCOME TRUST CLINICAL RESEARCH PROGRAMME 2017 GLOBAL HEALTH SYMPOSIUM UNIVERSITY
More informationResearch Article Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive Women Receiving ART in Uganda
Hindawi AIDS Research and Treatment Volume 2017, Article ID 3202737, 4 pages https://doi.org/10.1155/2017/3202737 Research Article Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive
More informationPharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women
Pharmacokinetic, Safety and Efficacy of Darunavir/Ritonavir in HIV+ Pregnant Women DR MINH LÊ PHARMACO-TOXICOLOGY DEPARTMENT APHP, HÔPITAL BICHAT-CLAUDE BERNARD PARIS, FRANCE ABSTRACT #O_01 17TH INTERNATIONAL
More informationWHO directives. This strategy has virtually contributed to the eradication of the disease in infancy, in many countries
A Retrospective Study of 63 infants born to HIV seropositive mothers in a Central Maternity Hospital of Greece, from 2011 to 2018 Eirini Koutsounaki Pediatrician Neonatologist Helena Venizelou NICU, Athens
More informationRequest for Proposals (RFP) for Sub-Studies
Request for Proposals (RFP) for Sub-Studies PROMISE IMPAACT 1077 BF, 1077FF and 1077HS Purpose: To provide the opportunity for further studies that build on the foundation of the IMPAACT PROMISE Study.
More informationZinplava. (bezlotoxumab) New Product Slideshow
Zinplava (bezlotoxumab) New Product Slideshow Introduction Brand name: Zinplava Generic name: Bezlotoxumab Pharmacological class: Human IgG1 monoclonal antibody Strength and Formulation: 25mg/mL; solution
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Linda-Gail Bekker With thanks to CN Mnyani SA HIV Clinician s Society Meeting 3 June 2017 We have effective drugs. There is no reason why any mother should die of AIDS. There
More informationA Systems Approach to Lifesaving Maternal and Newborn Care. Kate Cassidy, SMGL USAID Initiative Manager Mona Mehta Steffen, SMGL USAID M&E Advisor
A Systems Approach to Lifesaving Maternal and Newborn Care Kate Cassidy, SMGL USAID Initiative Manager Mona Mehta Steffen, SMGL USAID M&E Advisor Mini-U Presentation - March 4, 2016 Maternal & Newborn
More informationLabor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD
Labor & Delivery Management for Women Living with HIV Pooja Mittal, DO Lisa Rahangdale, MD Statistics for Perinatally Acquired HIV Timing of Perinatal HIV Transmission Most transmission occurs close to
More informationRESEARCH. 874 December 2014, Vol. 104, No. 12
Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: A cohort study at public facilities in the Nelson Mandela Bay
More information